PL3436571T3 - Sposób hodowli limfocytów B - Google Patents
Sposób hodowli limfocytów BInfo
- Publication number
- PL3436571T3 PL3436571T3 PL17713677.7T PL17713677T PL3436571T3 PL 3436571 T3 PL3436571 T3 PL 3436571T3 PL 17713677 T PL17713677 T PL 17713677T PL 3436571 T3 PL3436571 T3 PL 3436571T3
- Authority
- PL
- Poland
- Prior art keywords
- cultivation method
- cell cultivation
- cell
- cultivation
- Prior art date
Links
- 210000003719 b-lymphocyte Anatomy 0.000 title 1
- 238000004113 cell culture Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0635—B lymphocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2301—Interleukin-1 (IL-1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2302—Interleukin-2 (IL-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2304—Interleukin-4 (IL-4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2306—Interleukin-6 (IL-6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/231—Interleukin-10 (IL-10)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2321—Interleukin-21 (IL-21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/25—Tumour necrosing factors [TNF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
- C12N2502/1185—Thymus cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/30—Coculture with; Conditioned medium produced by tumour cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2525/00—Culture process characterised by gravity, e.g. microgravity
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16162954 | 2016-03-30 | ||
PCT/EP2017/057250 WO2017167714A1 (en) | 2016-03-30 | 2017-03-28 | B-cell cultivation method |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3436571T3 true PL3436571T3 (pl) | 2023-09-25 |
Family
ID=55806130
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL17713677.7T PL3436571T3 (pl) | 2016-03-30 | 2017-03-28 | Sposób hodowli limfocytów B |
Country Status (7)
Country | Link |
---|---|
US (3) | US10889802B2 (pl) |
EP (2) | EP4273232A3 (pl) |
JP (1) | JP7026634B2 (pl) |
CN (1) | CN108884442B (pl) |
ES (1) | ES2951698T3 (pl) |
PL (1) | PL3436571T3 (pl) |
WO (1) | WO2017167714A1 (pl) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2951698T3 (es) * | 2016-03-30 | 2023-10-24 | Hoffmann La Roche | Procedimiento de cultivo de linfocitos B |
EP3625332B1 (en) * | 2017-05-19 | 2022-02-02 | F. Hoffmann-La Roche AG | Method for the production of thymocyte supernatant |
JP7166342B2 (ja) | 2017-11-30 | 2022-11-07 | エフ.ホフマン-ラ ロシュ アーゲー | B細胞培養法 |
WO2024208936A1 (en) | 2023-04-05 | 2024-10-10 | F. Hoffmann-La Roche Ag | In vitro cultivation method for antibody expressing cells |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5637677A (en) | 1987-07-16 | 1997-06-10 | The Trustees Of The University Of Pennsylvania | Biologically active compounds and methods of constructing and using the same |
US5010182A (en) | 1987-07-28 | 1991-04-23 | Chiron Corporation | DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides |
AU4005289A (en) | 1988-08-25 | 1990-03-01 | Smithkline Beecham Corporation | Recombinant saccharomyces |
DE69126281T2 (de) * | 1990-11-26 | 1997-10-16 | Akzo Nobel Nv | Verfahren zur Herstellung von Antikörpern |
CA2321199A1 (en) | 1998-02-19 | 1999-08-26 | William A. Brady | Compositions and methods for regulating lymphocyte activation |
US20060051348A1 (en) | 2004-09-09 | 2006-03-09 | Jorn Gorlach | Method of producing a plurality of isolated antibodies to a plurality of cognate antigens |
WO2007049152A2 (en) | 2005-08-23 | 2007-05-03 | Iq Corporation | Methods of producing stable b-lymphocytes |
CA2622603C (en) | 2005-09-15 | 2014-06-17 | Crucell Holland B.V. | Method for preparing immunoglobulin libraries |
CA2652392C (en) | 2006-05-19 | 2017-10-10 | Alder Biopharmaceuticals, Inc. | Culture method for obtaining a clonal population of antigen-specific b cells |
US8642307B2 (en) | 2006-05-25 | 2014-02-04 | Nalge Nunc International Corporation | Cell culture surface chemistries |
US7731969B1 (en) * | 2006-12-06 | 2010-06-08 | Neoclone Biotechnology International, Llc | Methods for developing and producing antigen-specific antibody-producing cells |
HUE043782T2 (hu) | 2007-05-21 | 2019-09-30 | Alderbio Holdings Llc | IL-6 elleni antitestek és alkalmazásuk |
SI2400298T1 (sl) | 2010-05-28 | 2013-11-29 | F. Hoffmann-La Roche Ag | Postopek kultivacije posamezne B-celice in izdelava specifičnih protiteles |
US20130177987A1 (en) | 2011-06-24 | 2013-07-11 | Neoclone Biotechnology International, Llc | Methods for developing antigen-specific antibody-producing cell lines and monoclonal antibodies |
CN108192943B (zh) | 2011-11-23 | 2022-03-18 | 弗·哈夫曼-拉罗切有限公司 | 表达cd40l的哺乳动物细胞及其用途 |
JP2015500655A (ja) | 2011-12-21 | 2015-01-08 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 同起源の抗体可変領域遺伝子セグメントをクローニングおよび発現させるための迅速な方法 |
ES2951698T3 (es) * | 2016-03-30 | 2023-10-24 | Hoffmann La Roche | Procedimiento de cultivo de linfocitos B |
-
2017
- 2017-03-28 ES ES17713677T patent/ES2951698T3/es active Active
- 2017-03-28 EP EP23176295.6A patent/EP4273232A3/en active Pending
- 2017-03-28 CN CN201780020486.7A patent/CN108884442B/zh active Active
- 2017-03-28 JP JP2018551276A patent/JP7026634B2/ja active Active
- 2017-03-28 WO PCT/EP2017/057250 patent/WO2017167714A1/en active Application Filing
- 2017-03-28 PL PL17713677.7T patent/PL3436571T3/pl unknown
- 2017-03-28 EP EP17713677.7A patent/EP3436571B1/en active Active
-
2018
- 2018-09-27 US US16/144,240 patent/US10889802B2/en active Active
-
2020
- 2020-12-03 US US17/111,390 patent/US20210123019A1/en not_active Abandoned
-
2023
- 2023-06-30 US US18/345,891 patent/US20240002794A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP7026634B2 (ja) | 2022-02-28 |
EP3436571A1 (en) | 2019-02-06 |
CN108884442A (zh) | 2018-11-23 |
US10889802B2 (en) | 2021-01-12 |
EP4273232A3 (en) | 2024-01-03 |
ES2951698T3 (es) | 2023-10-24 |
EP4273232A2 (en) | 2023-11-08 |
JP2019513368A (ja) | 2019-05-30 |
EP3436571B1 (en) | 2023-06-14 |
US20190017022A1 (en) | 2019-01-17 |
US20240002794A1 (en) | 2024-01-04 |
US20210123019A1 (en) | 2021-04-29 |
WO2017167714A1 (en) | 2017-10-05 |
EP3436571C0 (en) | 2023-06-14 |
CN108884442B (zh) | 2023-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201610748D0 (en) | Improved diffrentation method | |
GB201607521D0 (en) | Method | |
GB201602394D0 (en) | Method | |
GB201601773D0 (en) | Method | |
EP3562936C0 (en) | METHODS FOR CULTIVATION OF B CELLS | |
GB201603367D0 (en) | Method | |
PL3436571T3 (pl) | Sposób hodowli limfocytów B | |
EP3523659C0 (en) | MULTI-PROTEASE PROCESS | |
GB201617886D0 (en) | Method | |
GB201607572D0 (en) | Alyklation method | |
GB201602927D0 (en) | Method | |
GB201601120D0 (en) | Eye-testing method | |
GB201711892D0 (en) | Improved culture methods | |
TWI560567B (en) | Password-transforming method | |
HUP1600433A2 (en) | Improved rice cultivation method | |
GB201616572D0 (en) | Method | |
GB201609241D0 (en) | Method | |
GB201608848D0 (en) | Method | |
GB201607463D0 (en) | Method | |
GB201604898D0 (en) | Method | |
GB201604620D0 (en) | Method | |
GB201604572D0 (en) | Method | |
GB201604291D0 (en) | Method | |
GB201604204D0 (en) | Method | |
GB201603731D0 (en) | Method |